Register entry
- Registered sites
- 2
- Active NDC listings
- 11
- Live patents
- 0
- Countries
- 1
- Base
- Japan
Authorisation
Registered operations
Analytical testing2Labelling2Finished drug manufacture2Packaging2
Sites
Registered establishments
2| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Bushu Pharmaceuticals, Ltd. | 1 Takeno, Kawagoe, Saitama 350-0801, Japan (JPN) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3005709762693460169 |
| Bushu Pharmaceuticals, Ltd. | 950 Hiroki, Misatomachi, Kodama-gun, Saitama 367-0198, Japan (JPN) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3011071488692386648 |
Catalogue
Drug listings by form and route
1111 active NDC listings: 11 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 11.
| Dosage form | NDCs |
|---|---|
| tablet, film coated | 9 |
| capsule, delayed release | 1 |
| tablet, delayed release | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| bushu pharmaceuticals, ltd. | 11 |
Catalogue
Marketed products
11| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Fezolinetant | tablet, film coated | 51148-014DRUG FOR FURTHER PROCESSING |
| - | LURASIDONE HYDROCHLORIDE | tablet, film coated | 51148-001DRUG FOR FURTHER PROCESSING |
| - | LURASIDONE HYDROCHLORIDE | tablet, film coated | 51148-002DRUG FOR FURTHER PROCESSING |
| - | LURASIDONE HYDROCHLORIDE | tablet, film coated | 51148-003DRUG FOR FURTHER PROCESSING |
| - | LURASIDONE HYDROCHLORIDE | tablet, film coated | 51148-004DRUG FOR FURTHER PROCESSING |
| - | Prevacid Capsule 30mg | capsule, delayed release | 51148-015DRUG FOR FURTHER PROCESSING |
| - | Rabeprazole sodium tablets | tablet, delayed release | 51148-007DRUG FOR FURTHER PROCESSING |
| - | Relugolix | tablet, film coated | 51148-013DRUG FOR FURTHER PROCESSING |
| - | Rufinamide | tablet, film coated | 51148-008DRUG FOR FURTHER PROCESSING |
| - | Rufinamide | tablet, film coated | 51148-009DRUG FOR FURTHER PROCESSING |
| - | Rufinamide | tablet, film coated | 51148-010DRUG FOR FURTHER PROCESSING |
Neighbours
Registered in the same town
1- Taiho Oncology, Inc.Kodama-gun, JPN
Compare
Comparable companies in Japan
- Sumitomo Pharma Co., Ltd.2 sites · 24 NDC
- Hisamitsu Pharmaceutical Co., Inc.2 sites · 16 NDC
- ASO Pharmaceutical Co. Ltd.2 sites · 10 NDC
- Lead Chemical Co., Ltd.2 sites · 7 NDC
- SUMITOMO OSAKA CEMENT CO., LTD.2 sites · 6 NDC
- Nipro Pharma Corporation2 sites · 2 NDC
- UBE Corporation2 sites · 1 NDC
- CMIC Pharma Science Co., Ltd.2 sites · 0 NDC
- Japan Food Research Laboratories2 sites · 0 NDC
- KATAYAMA SEIYAKUSYO CO., LTD.2 sites · 0 NDC
Enquiry
Common questions
- Is Bushu Pharmaceuticals, Ltd. FDA approved?
- Bushu Pharmaceuticals, Ltd. holds 2 FDA-registered establishments in Japan. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Bushu Pharmaceuticals, Ltd.'s drugs manufactured?
- The FDA register lists Kawagoe; Kodama-gun. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
- What drugs does Bushu Pharmaceuticals, Ltd. make?
- 11 products are listed under Bushu Pharmaceuticals, Ltd. in the openFDA NDC Directory, most often as tablet, film coated; capsule, delayed release; tablet, delayed release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.